APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

HER2 ADC Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global HER2 ADC Drugs Industry Growth and Trends Forecast to 2032

Report ID 173998080127 December 2025107 pages

Choose your research edition.

Industry ResearchHER2 ADC Drugs Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal HER2 ADC Drugs Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal HER2 ADC Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HER2 ADC Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal HER2 ADC Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global HER2 ADC Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for HER2 ADC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for HER2 ADC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for HER2 ADC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of HER2 ADC Drugs include CSPC Pharmaceutical Group, Hengrui Pharmaceuticals, BioNTech(Yingen Biopharmaceutical), Biokin Pharmaceutical, Takeda, RemeGen, MacroGenics, Genentech, Inc.(Roche) and Daiichi Sankyo, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global HER2 ADC Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The HER2 ADC Drugs market size, estimates, and forecasts are presented in terms of sales volume (K G) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global HER2 ADC Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to HER2 ADC Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global HER2 ADC Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

HER2 ADC Drugs Market by Company

CSPC Pharmaceutical Group

Hengrui Pharmaceuticals

BioNTech(Yingen Biopharmaceutical)

Biokin Pharmaceutical

Takeda

RemeGen

MacroGenics

Genentech, Inc.(Roche)

Daiichi Sankyo

AstraZeneca

HER2 ADC Drugs Segment by Type

RC48（Disitamab vedotin）

T-DM1（Kadcyla，Trastuzumab emtansine）

T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan）

HER2 ADC Drugs Segment by Application

Hospitals

Clinic

Others

HER2 ADC Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HER2 ADC Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HER2 ADC Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HER2 ADC Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of HER2 ADC Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of HER2 ADC Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of RC48（Disitamab vedotin） Table 2. Major Company of T-DM1（Kadcyla，Trastuzumab emtansine） Table 3. Major Company of T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan） Table 4. Global HER2 ADC Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global HER2 ADC Drugs Sales by Type (2021-2026) & (K G) Table 6. Global HER2 ADC Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global HER2 ADC Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global HER2 ADC Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global HER2 ADC Drugs Price by Type (2021-2026) & (US$/K G) Table 10. Global HER2 ADC Drugs Sales by Type (2027-2032) & (K G) Table 11. Global HER2 ADC Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global HER2 ADC Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global HER2 ADC Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global HER2 ADC Drugs Price by Type (2027-2032) & (US$/K G) Table 15. North America HER2 ADC Drugs Sales by Type (2021-2026) & (K G) Table 16. North America HER2 ADC Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe HER2 ADC Drugs Sales by Type (2021-2026) & (K G) Table 18. Europe HER2 ADC Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific HER2 ADC Drugs Sales by Type (2021-2026) & (K G) Table 20. Asia-Pacific HER2 ADC Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America HER2 ADC Drugs Sales by Type (2021-2026) & (K G) Table 22. Latin America HER2 ADC Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa HER2 ADC Drugs Sales by Type (2021-2026) & (K G) Table 24. Middle East and Africa HER2 ADC Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. HER2 ADC Drugs Industry Trends Table 26. HER2 ADC Drugs Industry Drivers Table 27. HER2 ADC Drugs Industry Opportunities and Challenges Table 28. HER2 ADC Drugs Industry Restraints Table 29. Global HER2 ADC Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global HER2 ADC Drugs Revenue Market Share by Company (2021-2026) Table 31. Global HER2 ADC Drugs Sales by Company (2021-2026) & (K G) Table 32. Global HER2 ADC Drugs Sales Share by Company (2021-2026) Table 33. Global HER2 ADC Drugs Market Price by Company (2021-2026) & (US$/K G) Table 34. Global HER2 ADC Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global HER2 ADC Drugs Major Company Production Sites and Headquarters Table 36. Global HER2 ADC Drugs Company, Product Type & Application Table 37. Global HER2 ADC Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global HER2 ADC Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global HER2 ADC Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global HER2 ADC Drugs Sales by Region (2021-2026) & (K G) Table 42. Global HER2 ADC Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global HER2 ADC Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global HER2 ADC Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global HER2 ADC Drugs Sales (K G), Value (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 46. Global HER2 ADC Drugs Sales by Region (2027-2032) & (K G) Table 47. Global HER2 ADC Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global HER2 ADC Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global HER2 ADC Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global HER2 ADC Drugs Sales (K G), Value (US$ Million), Price (US$/K G) and Gross Margin (2027-2032) Table 51. Global HER2 ADC Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global HER2 ADC Drugs Sales by Application (2021-2026) & (K G) Table 53. Global HER2 ADC Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global HER2 ADC Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global HER2 ADC Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global HER2 ADC Drugs Price by Application (2021-2026) & (US$/K G) Table 57. Global HER2 ADC Drugs Sales by Application (2027-2032) & (K G) Table 58. Global HER2 ADC Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global HER2 ADC Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global HER2 ADC Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global HER2 ADC Drugs Price by Application (2027-2032) & (US$/K G) Table 62. North America HER2 ADC Drugs Sales by Application (2021-2026) & (K G) Table 63. North America HER2 ADC Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe HER2 ADC Drugs Sales by Application (2021-2026) & (K G) Table 65. Europe HER2 ADC Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific HER2 ADC Drugs Sales by Application (2021-2026) & (K G) Table 67. Asia-Pacific HER2 ADC Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America HER2 ADC Drugs Sales by Application (2021-2026) & (K G) Table 69. Latin America HER2 ADC Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa HER2 ADC Drugs Sales by Application (2021-2026) & (K G) Table 71. Middle East and Africa HER2 ADC Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. CSPC Pharmaceutical Group Company Information Table 73. CSPC Pharmaceutical Group Business Overview Table 74. CSPC Pharmaceutical Group HER2 ADC Drugs Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 75. CSPC Pharmaceutical Group HER2 ADC Drugs Product Portfolio Table 76. CSPC Pharmaceutical Group Recent Development Table 77. Hengrui Pharmaceuticals Company Information Table 78. Hengrui Pharmaceuticals Business Overview Table 79. Hengrui Pharmaceuticals HER2 ADC Drugs Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 80. Hengrui Pharmaceuticals HER2 ADC Drugs Product Portfolio Table 81. Hengrui Pharmaceuticals Recent Development Table 82. BioNTech(Yingen Biopharmaceutical) Company Information Table 83. BioNTech(Yingen Biopharmaceutical) Business Overview Table 84. BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 85. BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Product Portfolio Table 86. BioNTech(Yingen Biopharmaceutical) Recent Development Table 87. Biokin Pharmaceutical Company Information Table 88. Biokin Pharmaceutical Business Overview Table 89. Biokin Pharmaceutical HER2 ADC Drugs Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 90. Biokin Pharmaceutical HER2 ADC Drugs Product Portfolio Table 91. Biokin Pharmaceutical Recent Development Table 92. Takeda Company Information Table 93. Takeda Business Overview Table 94. Takeda HER2 ADC Drugs Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 95. Takeda HER2 ADC Drugs Product Portfolio Table 96. Takeda Recent Development Table 97. RemeGen Company Information Table 98. RemeGen Business Overview Table 99. RemeGen HER2 ADC Drugs Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 100. RemeGen HER2 ADC Drugs Product Portfolio Table 101. RemeGen Recent Development Table 102. MacroGenics Company Information Table 103. MacroGenics Business Overview Table 104. MacroGenics HER2 ADC Drugs Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 105. MacroGenics HER2 ADC Drugs Product Portfolio Table 106. MacroGenics Recent Development Table 107. Genentech, Inc.(Roche) Company Information Table 108. Genentech, Inc.(Roche) Business Overview Table 109. Genentech, Inc.(Roche) HER2 ADC Drugs Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 110. Genentech, Inc.(Roche) HER2 ADC Drugs Product Portfolio Table 111. Genentech, Inc.(Roche) Recent Development Table 112. Daiichi Sankyo Company Information Table 113. Daiichi Sankyo Business Overview Table 114. Daiichi Sankyo HER2 ADC Drugs Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 115. Daiichi Sankyo HER2 ADC Drugs Product Portfolio Table 116. Daiichi Sankyo Recent Development Table 117. AstraZeneca Company Information Table 118. AstraZeneca Business Overview Table 119. AstraZeneca HER2 ADC Drugs Sales (K G), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 120. AstraZeneca HER2 ADC Drugs Product Portfolio Table 121. AstraZeneca Recent Development Table 122. North America HER2 ADC Drugs Market Size Growth Rate (CAGR) by Country (K G): 2021 VS 2025 VS 2032 Table 123. North America HER2 ADC Drugs Sales by Country (2021-2026) & (K G) Table 124. North America HER2 ADC Drugs Sales Market Share by Country (2021-2026) Table 125. North America HER2 ADC Drugs Sales Forecast by Country (2027-2032) & (K G) Table 126. North America HER2 ADC Drugs Sales Market Share Forecast by Country (2027-2032) Table 127. North America HER2 ADC Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America HER2 ADC Drugs Market Size by Country (2021-2026) & (US$ Million) Table 129. North America HER2 ADC Drugs Market Share by Country (2021-2026) Table 130. North America HER2 ADC Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America HER2 ADC Drugs Market Share Forecast by Country (2027-2032) Table 132. Europe HER2 ADC Drugs Market Size Growth Rate (CAGR) by Country (K G): 2021 VS 2025 VS 2032 Table 133. Europe HER2 ADC Drugs Sales by Country (2021-2026) & (K G) Table 134. Europe HER2 ADC Drugs Sales Market Share by Country (2021-2026) Table 135. Europe HER2 ADC Drugs Sales Forecast by Country (2027-2032) & (K G) Table 136. Europe HER2 ADC Drugs Sales Market Share Forecast by Country (2027-2032) Table 137. Europe HER2 ADC Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe HER2 ADC Drugs Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe HER2 ADC Drugs Market Share by Country (2021-2026) Table 140. Europe HER2 ADC Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe HER2 ADC Drugs Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific HER2 ADC Drugs Market Size Growth Rate (CAGR) by Country (K G): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific HER2 ADC Drugs Sales by Country (2021-2026) & (K G) Table 144. Asia-Pacific HER2 ADC Drugs Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific HER2 ADC Drugs Sales Forecast by Country (2027-2032) & (K G) Table 146. Asia-Pacific HER2 ADC Drugs Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific HER2 ADC Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific HER2 ADC Drugs Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific HER2 ADC Drugs Market Share by Country (2021-2026) Table 150. Asia-Pacific HER2 ADC Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific HER2 ADC Drugs Market Share Forecast by Country (2027-2032) Table 152. Latin America HER2 ADC Drugs Market Size Growth Rate (CAGR) by Country (K G): 2021 VS 2025 VS 2032 Table 153. Latin America HER2 ADC Drugs Sales by Country (2021-2026) & (K G) Table 154. Latin America HER2 ADC Drugs Sales Market Share by Country (2021-2026) Table 155. Latin America HER2 ADC Drugs Sales Forecast by Country (2027-2032) & (K G) Table 156. Latin America HER2 ADC Drugs Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America HER2 ADC Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America HER2 ADC Drugs Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America HER2 ADC Drugs Market Share by Country (2021-2026) Table 160. Latin America HER2 ADC Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America HER2 ADC Drugs Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa HER2 ADC Drugs Market Size Growth Rate (CAGR) by Country (K G): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa HER2 ADC Drugs Sales by Country (2021-2026) & (K G) Table 164. Middle East and Africa HER2 ADC Drugs Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa HER2 ADC Drugs Sales Forecast by Country (2027-2032) & (K G) Table 166. Middle East and Africa HER2 ADC Drugs Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa HER2 ADC Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa HER2 ADC Drugs Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa HER2 ADC Drugs Market Share by Country (2021-2026) Table 170. Middle East and Africa HER2 ADC Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa HER2 ADC Drugs Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. HER2 ADC Drugs Distributors List Table 175. HER2 ADC Drugs Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. HER2 ADC Drugs Image Figure 2. Global HER2 ADC Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HER2 ADC Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global HER2 ADC Drugs Sales (2021-2032) & (K G) Figure 5. RC48（Disitamab vedotin） Image Figure 6. Global RC48（Disitamab vedotin） Sales YoY Growth (2021-2032) & (K G) Figure 7. T-DM1（Kadcyla，Trastuzumab emtansine） Image Figure 8. Global T-DM1（Kadcyla，Trastuzumab emtansine） Sales YoY Growth (2021-2032) & (K G) Figure 9. T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan） Image Figure 10. Global T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan） Sales YoY Growth (2021-2032) & (K G) Figure 11. Global HER2 ADC Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global HER2 ADC Drugs Market Share by Type 2025 VS 2032 Figure 13. North America HER2 ADC Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America HER2 ADC Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe HER2 ADC Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe HER2 ADC Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific HER2 ADC Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific HER2 ADC Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America HER2 ADC Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America HER2 ADC Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa HER2 ADC Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa HER2 ADC Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 HER2 ADC Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (K G) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (K G) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K G) Figure 31. Global HER2 ADC Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global HER2 ADC Drugs Market Share by Application 2025 VS 2032 Figure 33. North America HER2 ADC Drugs Sales Market Share in Volume by Application in 2025 Figure 34. North America HER2 ADC Drugs Sales Market Share in Value by Application in 2025 Figure 35. Europe HER2 ADC Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Europe HER2 ADC Drugs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific HER2 ADC Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific HER2 ADC Drugs Sales Market Share in Value by Application in 2025 Figure 39. Latin America HER2 ADC Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America HER2 ADC Drugs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa HER2 ADC Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa HER2 ADC Drugs Sales Market Share in Value by Application in 2025 Figure 43. North America HER2 ADC Drugs Sales by Country: 2021 VS 2025 VS 2032 (K G) Figure 44. North America HER2 ADC Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America HER2 ADC Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America HER2 ADC Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe HER2 ADC Drugs Sales by Country: 2021 VS 2025 VS 2032 (K G) Figure 48. Europe HER2 ADC Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe HER2 ADC Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe HER2 ADC Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific HER2 ADC Drugs Sales by Country: 2021 VS 2025 VS 2032 (K G) Figure 52. Asia-Pacific HER2 ADC Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific HER2 ADC Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific HER2 ADC Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America HER2 ADC Drugs Sales by Country: 2021 VS 2025 VS 2032 (K G) Figure 56. Latin America HER2 ADC Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America HER2 ADC Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America HER2 ADC Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa HER2 ADC Drugs Sales by Country: 2021 VS 2025 VS 2032 (K G) Figure 60. Middle East and Africa HER2 ADC Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa HER2 ADC Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa HER2 ADC Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. HER2 ADC Drugs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. HER2 ADC Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • RC48（Disitamab vedotin）
  • T-DM1（Kadcyla，Trastuzumab emtansine）
  • T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan）
Applications
  • Hospitals
  • Clinic
  • Others
Companies covered
  • CSPC Pharmaceutical Group
  • Hengrui Pharmaceuticals
  • BioNTech(Yingen Biopharmaceutical)
  • Biokin Pharmaceutical
  • Takeda
  • RemeGen
  • MacroGenics
  • Genentech, Inc.(Roche)
  • Daiichi Sankyo
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global HER2 ADC Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global HER2 ADC Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 HER2 ADC Drugs Market by Type
  6. 1.3.1 RC48（Disitamab vedotin）
  7. 1.3.2 T-DM1（Kadcyla，Trastuzumab emtansine）
  8. 1.3.3 T-DXd（DS-8201，Enhertu，Trastuzumab deruxtecan）
  9. 1.4 Global HER2 ADC Drugs Market Size by Type
  10. 1.4.1 Global HER2 ADC Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global HER2 ADC Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global HER2 ADC Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America HER2 ADC Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe HER2 ADC Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific HER2 ADC Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America HER2 ADC Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa HER2 ADC Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 HER2 ADC Drugs Industry Trends
  2. 2.2 HER2 ADC Drugs Industry Drivers
  3. 2.3 HER2 ADC Drugs Industry Opportunities and Challenges
  4. 2.4 HER2 ADC Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by HER2 ADC Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by HER2 ADC Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by HER2 ADC Drugs Price (2021-2026)
  4. 3.4 Global HER2 ADC Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global HER2 ADC Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global HER2 ADC Drugs Company, Product Type & Application
  7. 3.7 Global HER2 ADC Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global HER2 ADC Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 HER2 ADC Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 HER2 ADC Drugs Tier 1, Tier 2, and Tier 3
4 HER2 ADC Drugs Regional Status and Outlook
  1. 4.1 Global HER2 ADC Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global HER2 ADC Drugs Historic Market Size by Region
  3. 4.2.1 Global HER2 ADC Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global HER2 ADC Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global HER2 ADC Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global HER2 ADC Drugs Forecasted Market Size by Region
  7. 4.3.1 Global HER2 ADC Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global HER2 ADC Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global HER2 ADC Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 HER2 ADC Drugs by Application
  1. 5.1 HER2 ADC Drugs Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global HER2 ADC Drugs Market Size by Application
  6. 5.2.1 Global HER2 ADC Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global HER2 ADC Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global HER2 ADC Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America HER2 ADC Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe HER2 ADC Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific HER2 ADC Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America HER2 ADC Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa HER2 ADC Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CSPC Pharmaceutical Group
  2. 6.1.1 CSPC Pharmaceutical Group Company Information
  3. 6.1.2 CSPC Pharmaceutical Group Business Overview
  4. 6.1.3 CSPC Pharmaceutical Group HER2 ADC Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CSPC Pharmaceutical Group HER2 ADC Drugs Product Portfolio
  6. 6.1.5 CSPC Pharmaceutical Group Recent Developments
  7. 6.2 Hengrui Pharmaceuticals
  8. 6.2.1 Hengrui Pharmaceuticals Company Information
  9. 6.2.2 Hengrui Pharmaceuticals Business Overview
  10. 6.2.3 Hengrui Pharmaceuticals HER2 ADC Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Hengrui Pharmaceuticals HER2 ADC Drugs Product Portfolio
  12. 6.2.5 Hengrui Pharmaceuticals Recent Developments
  13. 6.3 BioNTech(Yingen Biopharmaceutical)
  14. 6.3.1 BioNTech(Yingen Biopharmaceutical) Company Information
  15. 6.3.2 BioNTech(Yingen Biopharmaceutical) Business Overview
  16. 6.3.3 BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Product Portfolio
  18. 6.3.5 BioNTech(Yingen Biopharmaceutical) Recent Developments
  19. 6.4 Biokin Pharmaceutical
  20. 6.4.1 Biokin Pharmaceutical Company Information
  21. 6.4.2 Biokin Pharmaceutical Business Overview
  22. 6.4.3 Biokin Pharmaceutical HER2 ADC Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Biokin Pharmaceutical HER2 ADC Drugs Product Portfolio
  24. 6.4.5 Biokin Pharmaceutical Recent Developments
  25. 6.5 Takeda
  26. 6.5.1 Takeda Company Information
  27. 6.5.2 Takeda Business Overview
  28. 6.5.3 Takeda HER2 ADC Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Takeda HER2 ADC Drugs Product Portfolio
  30. 6.5.5 Takeda Recent Developments
  31. 6.6 RemeGen
  32. 6.6.1 RemeGen Company Information
  33. 6.6.2 RemeGen Business Overview
  34. 6.6.3 RemeGen HER2 ADC Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 RemeGen HER2 ADC Drugs Product Portfolio
  36. 6.6.5 RemeGen Recent Developments
  37. 6.7 MacroGenics
  38. 6.7.1 MacroGenics Company Information
  39. 6.7.2 MacroGenics Business Overview
  40. 6.7.3 MacroGenics HER2 ADC Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 MacroGenics HER2 ADC Drugs Product Portfolio
  42. 6.7.5 MacroGenics Recent Developments
  43. 6.8 Genentech, Inc.(Roche)
  44. 6.8.1 Genentech, Inc.(Roche) Company Information
  45. 6.8.2 Genentech, Inc.(Roche) Business Overview
  46. 6.8.3 Genentech, Inc.(Roche) HER2 ADC Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Genentech, Inc.(Roche) HER2 ADC Drugs Product Portfolio
  48. 6.8.5 Genentech, Inc.(Roche) Recent Developments
  49. 6.9 Daiichi Sankyo
  50. 6.9.1 Daiichi Sankyo Company Information
  51. 6.9.2 Daiichi Sankyo Business Overview
  52. 6.9.3 Daiichi Sankyo HER2 ADC Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Daiichi Sankyo HER2 ADC Drugs Product Portfolio
  54. 6.9.5 Daiichi Sankyo Recent Developments
  55. 6.10 AstraZeneca
  56. 6.10.1 AstraZeneca Company Information
  57. 6.10.2 AstraZeneca Business Overview
  58. 6.10.3 AstraZeneca HER2 ADC Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 AstraZeneca HER2 ADC Drugs Product Portfolio
  60. 6.10.5 AstraZeneca Recent Developments
7 North America by Country
  1. 7.1 North America HER2 ADC Drugs Sales by Country
  2. 7.1.1 North America HER2 ADC Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America HER2 ADC Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America HER2 ADC Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America HER2 ADC Drugs Market Size by Country
  6. 7.2.1 North America HER2 ADC Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America HER2 ADC Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America HER2 ADC Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe HER2 ADC Drugs Sales by Country
  2. 8.1.1 Europe HER2 ADC Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe HER2 ADC Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe HER2 ADC Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe HER2 ADC Drugs Market Size by Country
  6. 8.2.1 Europe HER2 ADC Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe HER2 ADC Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe HER2 ADC Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific HER2 ADC Drugs Sales by Country
  2. 9.1.1 Asia-Pacific HER2 ADC Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific HER2 ADC Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific HER2 ADC Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific HER2 ADC Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific HER2 ADC Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific HER2 ADC Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific HER2 ADC Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America HER2 ADC Drugs Sales by Country
  2. 10.1.1 South America HER2 ADC Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America HER2 ADC Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America HER2 ADC Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America HER2 ADC Drugs Market Size by Country
  6. 10.2.1 South America HER2 ADC Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America HER2 ADC Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America HER2 ADC Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa HER2 ADC Drugs Sales by Country
  2. 11.1.1 Middle East and Africa HER2 ADC Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa HER2 ADC Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa HER2 ADC Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa HER2 ADC Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa HER2 ADC Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa HER2 ADC Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa HER2 ADC Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 HER2 ADC Drugs Value Chain Analysis
  2. 12.1.1 HER2 ADC Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 HER2 ADC Drugs Production Mode & Process
  7. 12.2 HER2 ADC Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 HER2 ADC Drugs Distributors
  10. 12.2.3 HER2 ADC Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst